NASDAQ:PHVS

Pharvaris B.v Stock Insider Trading

etoro logo Buy PHVS
*Your capital is at risk
$32.62
-1.26 (-3.72%)
At Close: Jul 31, 2026

Pharvaris B.V Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -96.62. In total, the insiders bought 314.07K and sold 358.94K PHVS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-96.62
Buy 314.07K shares
Sell 358.94K shares
48% Buy Activity
Weak Positive Correlation
Sell Signal Medium Confidence
Jun 30, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -96.62.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 25, 2026
Sell
Common Stock
S-Sale
Lesage Anne
Chief Early Development
Officer 2 300
Value: $80.8K
Jun 25, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Lesage Anne
Chief Early Development
Officer 900
Value: $7K
Jun 25, 2026
Buy
Common Stock
M-Exempt
Lesage Anne
Chief Early Development
Officer 900
Value: $7K
Jun 25, 2026
Buy
Common Stock
M-Exempt
Lesage Anne
Chief Early Development
Officer 1 400
Value: $4K
Jun 25, 2026
Sell
Common Stock
S-Sale
Lesage Anne
Chief Early Development
Officer 2 300
Value: $80.8K
Jun 25, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Lesage Anne
Chief Early Development
Officer 1 400
Value: $4K
Jun 25, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Lu Peng
Chief Medical Officer
Officer 15 000
Value: $38.9K
Jun 25, 2026
Buy
Common Stock
M-Exempt
Lu Peng
Chief Medical Officer
Officer 15 000
Value: $38.9K
Jun 25, 2026
Sell
Common Stock
S-Sale
Lu Peng
Chief Medical Officer
Officer 11 600
Value: $399.7K
Jun 25, 2026
Sell
Common Stock
S-Sale
Lu Peng
Chief Medical Officer
Officer 3 400
Value: $119.3K
Jun 18, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Lu Peng
Chief Medical Officer
Officer 300
Value: $777
Jun 18, 2026
Buy
Common Stock
M-Exempt
Lu Peng
Chief Medical Officer
Officer 300
Value: $777
Jun 18, 2026
Sell
Common Stock
S-Sale
Lu Peng
Chief Medical Officer
Officer 300
Value: $10.2K
Jun 15, 2026
Sell
Common Stock
S-Sale
Modig Berndt
Chief Executive Officer
CEO / President 2 191
Value: $68.0K
Jun 15, 2026
Sell
Common Stock
S-Sale
Modig Berndt
Chief Executive Officer
CEO / President 100
Value: $3K
Jun 12, 2026
Sell
Common Stock
F-InKind
Lu Peng
Chief Medical Officer
Officer 117
Value: $4K
Jun 11, 2026
Sell
Common Stock
F-InKind
Lu Peng
Chief Medical Officer
Officer 109
Value: $3K
Jun 04, 2026
Sell
Common Stock
S-Sale
Nijdam Anna
Principal Accounting Officer
Officer 2 670
Value: $82.4K
May 22, 2026
Buy
Common Stock
M-Exempt
Nijdam Anna
Principal Accounting Officer
Officer 5 501
Value: $110.0K
May 22, 2026
Sell
Common Stock
S-Sale
Nijdam Anna
Principal Accounting Officer
Officer 5 501
Value: $169.1K
May 22, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Nijdam Anna
Principal Accounting Officer
Officer 5 501
Value: $110.0K
May 21, 2026
Sell
Common Stock
S-Sale
Monges Viviane
Director
Director 9 667
Value: $292.9K
May 21, 2026
Buy
Common Stock
M-Exempt
Nijdam Anna
Principal Accounting Officer
Officer 1 829
Value: $36.6K
May 21, 2026
Sell
Common Stock
S-Sale
Nijdam Anna
Principal Accounting Officer
Officer 1 829
Value: $56.0K
May 21, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Nijdam Anna
Principal Accounting Officer
Officer 1 829
Value: $36.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PHARVARIS B.V.
Pharvaris B.V
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE